Annual Total Expenses
$55.14 B
-$7.92 B-12.56%
31 December 2023
Summary:
Pfizer annual total expenses is currently $55.14 billion, with the most recent change of -$7.92 billion (-12.56%) on 31 December 2023. During the last 3 years, it has risen by +$22.32 billion (+67.99%). PFE annual total expenses is now -12.56% below its all-time high of $63.06 billion, reached on 31 December 2022.PFE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$12.42 B
+$1.40 B+12.68%
30 September 2024
Summary:
Pfizer quarterly total expenses is currently $12.42 billion, with the most recent change of +$1.40 billion (+12.68%) on 30 September 2024. Over the past year, it has dropped by -$4.02 billion (-24.47%). PFE quarterly total expenses is now -34.78% below its all-time high of $19.04 billion, reached on 31 December 2022.PFE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.6% | -24.5% |
3 y3 years | +68.0% | -24.6% |
5 y5 years | +61.7% | +32.7% |
PFE Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -12.6% | +68.0% | -34.8% | +17.5% |
5 y | 5 years | -12.6% | +68.0% | -34.8% | +92.0% |
alltime | all time | -12.6% | +1725.1% | -34.8% | +955.3% |
Pfizer Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $12.42 B(+12.7%) |
June 2024 | - | $11.02 B(+3.2%) |
Mar 2024 | - | $10.68 B(-34.2%) |
Dec 2023 | $55.14 B(-12.6%) | $16.22 B(-1.3%) |
Sept 2023 | - | $16.44 B(+55.6%) |
June 2023 | - | $10.57 B(-11.3%) |
Mar 2023 | - | $11.91 B(-37.4%) |
Dec 2022 | $63.06 B(+9.5%) | $19.04 B(+46.8%) |
Sept 2022 | - | $12.97 B(-15.4%) |
June 2022 | - | $15.33 B(-2.4%) |
Mar 2022 | - | $15.71 B(-13.9%) |
Dec 2021 | $57.58 B(+75.4%) | $18.24 B(+10.7%) |
Sept 2021 | - | $16.48 B(+26.0%) |
June 2021 | - | $13.07 B(+33.6%) |
Mar 2021 | - | $9.79 B(-7.3%) |
Dec 2020 | $32.82 B(-2.3%) | $10.56 B(+34.9%) |
Sept 2020 | - | $7.83 B(+5.3%) |
June 2020 | - | $7.43 B(+6.1%) |
Mar 2020 | - | $7.00 B(+8.3%) |
Dec 2019 | $33.59 B(-1.5%) | $6.47 B(-30.9%) |
Sept 2019 | - | $9.36 B(+2.7%) |
June 2019 | - | $9.11 B(+5.3%) |
Mar 2019 | - | $8.66 B(+37.8%) |
Dec 2018 | $34.09 B(-11.4%) | $6.29 B(-33.5%) |
Sept 2018 | - | $9.45 B(+0.0%) |
June 2018 | - | $9.45 B(+6.0%) |
Mar 2018 | - | $8.91 B(-21.2%) |
Dec 2017 | $38.47 B(-1.6%) | $11.31 B(+20.5%) |
Sept 2017 | - | $9.39 B(+3.4%) |
June 2017 | - | $9.09 B(+4.6%) |
Mar 2017 | - | $8.69 B(-23.1%) |
Dec 2016 | $39.11 B(+9.0%) | $11.29 B(+19.0%) |
Sept 2016 | - | $9.49 B(+1.5%) |
June 2016 | - | $9.35 B(+4.2%) |
Mar 2016 | - | $8.97 B(-23.9%) |
Dec 2015 | $35.88 B(-0.6%) | $11.79 B(+44.6%) |
Sept 2015 | - | $8.15 B(-0.3%) |
June 2015 | - | $8.17 B(+5.2%) |
Mar 2015 | - | $7.77 B(-28.4%) |
Dec 2014 | $36.11 B(+2.5%) | $10.84 B(+24.6%) |
Sept 2014 | - | $8.70 B(-0.5%) |
June 2014 | - | $8.74 B(+11.7%) |
Mar 2014 | - | $7.83 B(-20.8%) |
Dec 2013 | $35.22 B(-6.3%) | $9.88 B(+17.3%) |
Sept 2013 | - | $8.43 B(-0.9%) |
June 2013 | - | $8.50 B(+1.1%) |
Mar 2013 | - | $8.41 B(-18.6%) |
Dec 2012 | $37.58 B(-15.0%) | $10.33 B(+16.1%) |
Sept 2012 | - | $8.90 B(-0.2%) |
June 2012 | - | $8.92 B(-12.5%) |
Mar 2012 | - | $10.20 B(+7.1%) |
Dec 2011 | $44.23 B(-9.0%) | $9.52 B(-16.7%) |
Sept 2011 | - | $11.43 B(-4.6%) |
June 2011 | - | $11.99 B(+2.8%) |
Mar 2011 | - | $11.66 B(+10.0%) |
Dec 2010 | $48.61 B(+41.8%) | $10.60 B(-22.9%) |
Sept 2010 | - | $13.76 B(+14.5%) |
June 2010 | - | $12.02 B(-1.8%) |
Mar 2010 | - | $12.24 B(-6.0%) |
Dec 2009 | $34.29 B(-6.6%) | $13.02 B(+79.3%) |
Sept 2009 | - | $7.26 B(-2.0%) |
June 2009 | - | $7.40 B(+13.7%) |
Mar 2009 | - | $6.51 B(-44.4%) |
Dec 2008 | $36.70 B(-3.6%) | $11.72 B(+43.8%) |
Sept 2008 | - | $8.15 B(-8.8%) |
June 2008 | - | $8.94 B(+11.0%) |
Mar 2008 | - | $8.05 B(-21.8%) |
Dec 2007 | $38.08 B(+11.7%) | $10.29 B(-7.8%) |
Sept 2007 | - | $11.16 B(+25.4%) |
June 2007 | - | $8.90 B(+15.2%) |
Mar 2007 | - | $7.73 B(-22.8%) |
Dec 2006 | $34.09 B | $10.01 B(+18.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2006 | - | $8.41 B(+2.1%) |
June 2006 | - | $8.24 B(+10.8%) |
Mar 2006 | - | $7.43 B(-18.6%) |
Dec 2005 | $33.20 B(+2.0%) | $9.14 B(+18.5%) |
Sept 2005 | - | $7.71 B(-6.1%) |
June 2005 | - | $8.21 B(-7.9%) |
Mar 2005 | - | $8.92 B(+22.3%) |
Dec 2004 | $32.56 B(-5.3%) | $7.30 B(-13.2%) |
Sept 2004 | - | $8.41 B(-2.9%) |
June 2004 | - | $8.66 B(+5.6%) |
Mar 2004 | - | $8.20 B(-27.4%) |
Dec 2003 | $34.37 B(+71.2%) | $11.30 B(+15.8%) |
Sept 2003 | - | $9.76 B(+21.5%) |
June 2003 | - | $8.03 B(+59.7%) |
Mar 2003 | - | $5.03 B(-11.0%) |
Dec 2002 | $20.07 B(+9.0%) | $5.65 B(+14.6%) |
Sept 2002 | - | $4.93 B(+2.3%) |
June 2002 | - | $4.82 B(+3.2%) |
Mar 2002 | - | $4.67 B(+30.6%) |
Dec 2001 | $18.41 B(-11.4%) | $3.58 B(-28.3%) |
Sept 2001 | - | $4.99 B(-2.3%) |
June 2001 | - | $5.10 B(+5.0%) |
Mar 2001 | - | $4.86 B(-14.7%) |
Dec 2000 | $20.79 B(+1.8%) | $5.70 B(+15.8%) |
Sept 2000 | - | $4.92 B(-3.8%) |
June 2000 | - | $5.12 B(+1.2%) |
Mar 2000 | - | $5.05 B(-10.1%) |
Dec 1999 | $20.41 B(+14.2%) | $5.62 B(+8.6%) |
Sept 1999 | - | $5.17 B(+8.1%) |
June 1999 | - | $4.79 B(+72.8%) |
Mar 1999 | - | $2.77 B(-74.8%) |
Dec 1998 | $17.88 B(+124.0%) | $11.01 B(+369.1%) |
Sept 1998 | - | $2.35 B(-2.2%) |
June 1998 | - | $2.40 B(+13.1%) |
Mar 1998 | - | $2.12 B(-9.0%) |
Dec 1997 | $7.98 B(+12.1%) | $2.33 B(+21.5%) |
Sept 1997 | - | $1.92 B(-13.3%) |
June 1997 | - | $2.22 B(+6.9%) |
Mar 1997 | - | $2.07 B(+65.2%) |
Dec 1996 | $7.12 B(-4.6%) | $1.25 B(-36.3%) |
Sept 1996 | - | $1.97 B(-5.7%) |
June 1996 | - | $2.09 B(+11.4%) |
Mar 1996 | - | $1.87 B(-9.5%) |
Dec 1995 | $7.46 B(+18.3%) | $2.07 B(+12.1%) |
Sept 1995 | - | $1.85 B(-5.1%) |
June 1995 | - | $1.95 B(+9.8%) |
Mar 1995 | - | $1.77 B(-1.4%) |
Dec 1994 | $6.31 B(-3.9%) | $1.80 B(+14.6%) |
Sept 1994 | - | $1.57 B(+2.7%) |
June 1994 | - | $1.53 B(+7.7%) |
Mar 1994 | - | $1.42 B(-39.3%) |
Dec 1993 | $6.56 B(+13.4%) | $2.33 B(+63.9%) |
Sept 1993 | - | $1.42 B(+19.2%) |
June 1993 | - | $1.20 B(-13.4%) |
Mar 1993 | - | $1.38 B(-13.2%) |
Dec 1992 | $5.79 B(+1.6%) | $1.59 B(+11.6%) |
Sept 1992 | - | $1.42 B(+0.3%) |
June 1992 | - | $1.42 B(+5.0%) |
Mar 1992 | - | $1.35 B(-14.9%) |
Dec 1991 | $5.70 B(+6.4%) | $1.59 B(+13.6%) |
Sept 1991 | - | $1.40 B(+1.1%) |
June 1991 | - | $1.38 B(+4.6%) |
Mar 1991 | - | $1.32 B(-16.0%) |
Dec 1990 | $5.35 B(+13.8%) | $1.57 B(+19.8%) |
Sept 1990 | - | $1.31 B(+2.2%) |
June 1990 | - | $1.29 B(+9.3%) |
Mar 1990 | - | $1.18 B |
Dec 1989 | $4.70 B(+7.5%) | - |
Dec 1988 | $4.37 B(+9.9%) | - |
Dec 1987 | $3.98 B(+13.2%) | - |
Dec 1986 | $3.52 B(+11.8%) | - |
Dec 1985 | $3.14 B(+4.1%) | - |
Dec 1984 | $3.02 B | - |
FAQ
- What is Pfizer annual total expenses?
- What is the all time high annual total expenses for Pfizer?
- What is Pfizer annual total expenses year-on-year change?
- What is Pfizer quarterly total expenses?
- What is the all time high quarterly total expenses for Pfizer?
- What is Pfizer quarterly total expenses year-on-year change?
What is Pfizer annual total expenses?
The current annual total expenses of PFE is $55.14 B
What is the all time high annual total expenses for Pfizer?
Pfizer all-time high annual total expenses is $63.06 B
What is Pfizer annual total expenses year-on-year change?
Over the past year, PFE annual total expenses has changed by -$7.92 B (-12.56%)
What is Pfizer quarterly total expenses?
The current quarterly total expenses of PFE is $12.42 B
What is the all time high quarterly total expenses for Pfizer?
Pfizer all-time high quarterly total expenses is $19.04 B
What is Pfizer quarterly total expenses year-on-year change?
Over the past year, PFE quarterly total expenses has changed by -$4.02 B (-24.47%)